Treatment of aspergillus infections with thymosin alpha 1
摘要
The use of an antifungal effective amount of thymosin alpha 1 (TA1) in the manufacture of a pharmaceutical composition for treating or preventing an Aspergillus infection in a mammal.
申请公布号
NZ542900(A)
申请公布日期
2007.06.29
申请号
NZ20040542900
申请日期
2004.03.29
申请人
SCICLONE PHARMACEUTICALS, INC
发明人
RASI, GUIDO;GARACI, ENRICO;BISTONI, FRANCESCO;ROMANI, LUIGINA;DI FRANCESCO, PAOLO
